A carregar...
Prognostic Role of Methylation Status of the MGMT Promoter Determined Quantitatively by Pyrosequencing in Glioblastoma Patients
OBJECTIVE: This study investigated whether pyrosequencing can be used to determine the methylation status of the MGMT promoter as a clinical biomarker using relatively old archival tissue samples of glioblastoma. We also examined other prognostic factors for survival of glioblastoma patients. METHOD...
Na minha lista:
| Publicado no: | J Korean Neurosurg Soc |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
The Korean Neurosurgical Society
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4754584/ https://ncbi.nlm.nih.gov/pubmed/26885283 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3340/jkns.2016.59.1.26 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|